| Yujiro S. Hata | President and Chief Executive Officer | FY2025 | |
| Joshua Bleharski, Ph.D. | Chief Financial Officer | FY2025 | |
| Darrin M. Beaupre, M.D., Ph.D. | Chief Medical Officer | FY2025 | |
| Michael A. White, Ph.D. | Chief Scientific Officer | FY2025 | |
| Andres Ruiz Briseno | Chief Accounting Officer | FY2025 | |
| Douglas B. Snyder | Chief Legal Officer | FY2025 |
6 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.